1. Каталог >
  2. Клетки, микроорганизмы, среды >
  3. Клеточные линии >
  4. Клеточные линии по типам >
  5. Эндотелий: клетки >

Клетки эндотелия пупочной вены человека: HUVEC. Первичные клеточные линии Cell Applications.

Human Umbilical Vein Endothelial Cells: HUVEC

HUVEC Клетки Эндотелия Пупочной Вены Человека (HUVEC) предоставляют классическую модельную систему для изучения многих аспектов функций и заболеваний эндотелия, таких как нормальный, аномальный и связанных с опухолями ангиогенез, оксидативный стрес, гипоксия и воспаления, связанные с ними сигнальные пути в эндотелии в нормальных и патологических условиях, связанные с сердечно-сосудистые осложнения, связанные с различными заболеваниями, способы действия и защитные эффекты различных соединений и т.д.  Избранные лоты HUVEC были дополнительно тестированы для демонстрации стимуляционно-зависимого ангиогенеза и ключевых для эндотелиальных клеток сигнальных путей (фосфорилирование VEGFR, Akt, MAPK, и экспрессию Tie2, eNOS, Axl и Etk/Bmx). Более подробную информацию смотрите в разделе Тестированные Эндотелиальные Клетки.

HUVEC от Cell Applications, Inc. были использованы во многих исследованиях, например:

(Текст на языке оригинала)
  • Understand anti-inflammatory properties of HDL
  • Develop scaffolds for tissue engineering
  • Characterize endothelial cell response to stress and discover mechanisms that protect mitochondria against oxidative stress
  • Demonstrate that prolonged hypoxia induces MMP-1 expression, EC migration and angiogenesis
  • Show that Alzheimer’s β-amyloid peptide exhibits anti-angiogenic properties
  • Demonstrate for the first time that mature miRNA can control gene expression in a cell where it is neither transcribed nor processed
  • Show that abnormal matrix composition characteristic for systemic sclerosis leads to impaired vascular function and angiogenesis
  • Discover novel mechanisms of inhibiting tumor angiogenesis and metastasis, by limiting EC migration and proliferation, as well as the expression of growth factors and enzymes
  • Develop a bubble lyposome based system that enables therapeutic miRNA delivery
  • Demonstrate that commercially used flame retardants cause oxidative stress
  • Show that hyperglycemia leads to endothelial dysfunction, partially due to depletion of antioxidants, and that regaining glycemic control normalizes growth factor levels in ischemia and improves perfusion recovery
  • Show that inhibition of aldose reductase inhibits migration and formation of capillary-like structures by endothelial cells
  • Investigate effects of molecular mobility of the outmost material surfaces on cellular adhesion and organization
  • Identify signaling differences in cells cultured on different ECM components.
  • Investigate mechanisms of cardiovascular protection exerted by bioactive plant and fungal components
  • Show that in low doses coumaric acid and resveratrol provide beneficial effects and protect endothelial cells from reactive oxygen species
  • Show that combined treatment with melatonin and atorvastatin reversed damage to EC, partly by reducing free radical generation and lipid peroxidation
  • Discover that deferoxamine (DFO), an iron-chelating agent, mitigates deleterious effects of radiation on angiogenesis
  • Study the differential effects of wood smoke and diesel exhaust particles, as well as carbon nanotubes on inducing oxidative stress and production of cytokines and adhesion molecules in endothelia


Human normal umbilical vein.  Each lot is tested negative for HIV, Hepatitis B, Hepatitis C, mycoplasma, bacteria, and fungi.
Cryopreserved ampoule:
Primary culture, >500,000 cells in Endothelial Cell Basal Medium containing 10% FBS & 10% DMSO.
Kit contains:
Ampoule of cryopreserved HUVEC (200-05n), 500 ml Endothelial Cell Growth Medium (211-500), and a Subculture Reagent Kit (090K).
Proliferating Cells:
Shipped in Endothelial Cell Transfer Medium at 1st passage in either flasks or multiwell dishes.
Population doublings:
Can be cultured at least 16 doublings



Lansford, K., D. Shill, A. Dicks, M. Marshburn, W. Southern. And N. Jenkins. 2016. Effect of acute exercise on circulating angiogenic cell and microparticle populations. Experimental Physiology, 101:155-167.
Basudhara, D., R. Chengb, G. Bharadwaja, L. Ridnourb, D. Winkb, and K. Mirandaa. 2015. Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast Cancer. Free Radical Biology and Medicine, 4 February.
Berg, E., M. Polokoff, A. O’Mahony, D. Nguyen, and X Li. 2015. Elucidating Mechanisms of Toxicity Using Phenotypic Data from Primary Human Cell Systems—A Chemical Biology Approach for Thrombosis-Related Side Effects. International, Journal of Molecular Sciences, 16:1008-1029.
Boire, T., M. Gupta, A. Zachman, S. Lee, D. Balikov, K. Kim, L. Bellan, and H. Sung. 2015. Pendant Allyl Crosslinking as a Tunable Shape Memory Actuator for Vascular Applications. Acta Biomaterialia, doi:10.1016/j.actbio.2015.06.004.Dokun, A., L. Chen, M. Okutsu, C. Farber, S. Hazarika, W. Jones, D. Craig, D. Marchuk, J. Lye, S. Shan, and B. Annex. 2015. ADAM12: A Genetic Modifier of Pre-clinical Peripheral Arterial Disease. Am J Physiol, DOI: 10.1152/ajpheart.00803.2014.
Huang, B., J. Cheng, C. Wu, P. Chen, P. Tu, Y. Fu, and C. Wu. 2015. Camptothecin promotes the production of nitric oxide that triggers subsequent S-nitrosoproteome-mediated signaling cascades in endothelial cells. Vascular Pharmacol, doi:10.1016/j.vph.2015.07.014.
Kim, K., Y. Lee, H. Ji, R. Song, J. Kim, S. Lee, S. Hong, M. Yoo, and H. Yang. 2015. Increased expression of endocan in arthritic synovial tissues: Effects of adiponectin on the expression of endocan in fibroblast-like synoviocytes. Molecular Medicine Reports, 11:2695-2702.
Klingberg, H., L. Oddershede, K. Loeschner, E. Larsen, S. Lofta, and Møller. 2015. Uptake of gold nanoparticles in primary human endothelial cells. Toxicology Research, Advance Article, DOI: 10.1039/C4TX00061G.
Liu, Y., Q. Chen, M. Xu, G. Guan, W. Hu, Y. Liang, X. Zhao, M. Qiao, D. Chen, and H. Liu. 2015. Single peptide ligand-functionalized uniform hollow mesoporous silica nanoparticles achieving dual-targeting drug delivery to tumor cells and angiogenic blood vessel cells. International Journal of Nanomedicine, 10:1855-1867.
Cao, Y., N.R. Jacobsen, P.H. Danielsen, A.G. Lenz, T. Stoeger, S. Loft, H. Wallin, M. Roursgaard, L. Mikkelsen, and P. Møller. 2014. Vascular Effects of Multiwalled Carbon Nanotubes in Dyslipidemic ApoE −/− Mice and Cultured Endothelial Cells. Toxicological Sciences. 138:104-116.
Cha, B., H. Kwak, A. Park, S. Kim, S. Park, H. Kim, I. Kim, K. Lee, and Y. Park. 2014. Structural characteristics and biological performance of silk fibroin nanofiber containing microalgae spirulina extract. Biopolymers, 101:307-318.
Dokun, A. L. Chen, S. Lanjewar, J. Lye, and B. Annex. 2014. Glycemic Control Improves Perfusion Recovery and VEGFR2 Protein Expression in Diabetic Mice Following Experimental PAD. Cardiovascular Research, 101:364-372.
Endo-Takahashi, Y., Y. Negishi, A. Nakamura, S. Ukai, K. Ooaku, Y. Oda, K. Sugimoto, F. Moriyasu, N. Takagi, R. Suzuki, K. Maruyama, and Y. Aramaki. 2014.   Systemic delivery of miR-126 by miRNA-loaded Bubble liposomes for the treatment of hindlimb ischemia. Scientific Reports 4, Article number: 3883.
Lu, J., X Li, Y. Jin, and M. Chen. 2014. Endoplasmic reticulum stress-mediated aldosterone-induced apoptosis in vascular endothelial cells. J. Huazhong Univ Sci Technol, 34:821-824.
Sahara, M. E. Hansson, O. Wernet, K. Lui, D. Später, and K. Chien. 2014. Manipulation of a VEGF-Notch signaling circuit drives formation of functional vascular endothelial progenitors from human pluripotent stem cells. Cell Research, 24:820-841.
Sasahira, T., N. Ueda, K. Yamamoto, M. Kurihara, S. Matsushima, U.K. Bhawal, T. Kirita, and H. Kuniyasu. 2014. Prox1 and FOXC2 Act as Regulators of Lymphangiogenesis and Angiogenesis in Oral Squamous Cell Carcinoma. PloS one. 9:e92534.
Savoji, H., A. Hadjizadeh, M. Maire, A. Ajji, M. Wertheimer, and S. Lerouge. 2014. Electrospun Nanofiber Scaffolds and Plasma Polymerization: A Promising Combination Towards Complete, Stable Endothelial Lining for Vascular Grafts. Macromolecular Bioscience, 14:1084-1095.
Tabet, F., K.C. Vickers, L.F. Cuesta Torres, C.B. Wiese, B.M. Shoucri, G. Lambert, C. Catherinet, L. Prado-Lourenco, M.G. Levin, S. Thacker, P. Sethupathy, P.J. Barter, A.T. Remaley, and K.-A. Rye. 2014. HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nat Commun. 5:10.1038/ncomms4292.
Takemoto, K., S. Kamisuki, P. Chia, I. Kuriyama, Y. Mizushina, and F. Sugawara. 2014. Bioactive Dihydronaphthoquinone Derivatives from Fusarium solani. J Nat Prod, 77:1992-1996.
Yin, C., Y. Liang, S. Guo, X. Zhou, and X. Pan. 2014. CCN1 enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia. Molecular Biology Reports, 41:5813-5818.
Zhen, A., S. Krutzik, B. Levin, S. Kasparian, J. Zack, and X. Kitchen. 2014. CD4 ligation on human blood monocytes triggers macrophage differentiation and enhances HIV infection. J Virol, 88:9934-9946.
Cha, B.G., H.W. Kwak, A.R. Park, S.H. Kim, S.Y. Park, H.J. Kim, I.S. Kim, K.H. Lee, and Y.H. Park. 2013. Structural characteristics and biological performance of silk fibroin nanofiber containing microalgae spirulina extract 6. Peptide Science:DOI: 10.1002/bip.22359.
Chen, Z., T.C. Lai, Y.H. Jan, F.M. Lin, W.C. Wang, H. Xiao, Y.T. Wang, W. Sun, X. Cui, Y.S. Li, T. Fang, H. Zhao, C. Padmanabhan, R. Sun, D.L. Wang, H. Jin, G.Y. Chau, H.D. Huang, M. Hsiao, and J.Y.J. Shyy. 2013. Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis. The Journal of clinical investigation. 123:1057-1067.
Kaakinen, M., S. Huttunen, L. Paavolainen, V. MarjomÄKi, J. HeikkilÄ, and L. Eklund. 2013. Automatic detection and analysis of cell motility in phase-contrast time-lapse images using a combination of maximally stable extremal regions and Kalman filter approaches. Journal of Microscopy. 253:65-78.
Lohr, N.L., J.T. Ninomiya, D.C. Warltier, and D.e. Weihrauch. 2013. Far red/near infrared light treatment promotes femoral artery collateralization in the ischemic hindlimb 2. Journal of Molecular and Cellular Cardiology. 62:36-42.
Mazor, R., T. Alsaigh, H. Shaked, A.E. Altshuler, E.S. Pocock, E.B. Kistler, M. Karin, and G.W. Schmid-Sch+Ýnbein. 2013. Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells. The Journal of biological chemistry. 288:598-607.
Nakayama, K. 2013a. cAMP-response Element-binding Protein (CREB) and NF-κB Transcription Factors Are Activated during Prolonged Hypoxia and Cooperatively Regulate the Induction of Matrix Metalloproteinase MMP1. Journal of Biological Chemistry. 288:22584-22595.
Nakayama, K. 2013b. CREB and NF-κB are activated during prolonged hypoxia and cooperatively regulate the induction of matrix metalloproteinase MMP1. Journal of Biological Chemistry. 288:22584-22589.
Pallet, N., I. Sirois, C. Bell, L.l.A.c. Hanafi, K. Hamelin, M. Dieud+ª, C. Rondeau, P. Thibault, M. Desjardins, and M.J.e. Hebert. 2013. A comprehensive characterization of membrane vesicles released by autophagic human endothelial cells 7. PROTEOMICS. 13:1108-1120.
Takizawa, Y., Y. Kosuge, H. Awaji, E. Tamura, A. Takai, T. Yanai, R. Yamamoto, K. Kokame, T. Miyata, and R. Nakata. 2013. Up-regulation of endothelial nitric oxide synthase (eNOS), silent mating type information regulation 2 homologue 1 (SIRT1) and autophagy-related genes by repeated treatments with resveratrol in human umbilical vein endothelial cells. The British journal of nutrition:1-6.
Tseng, A.H.H., S.-S. Shieh, and D.L. Wang. 2013. SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage. Free Radical Biology and Medicine. 63:222-234.
Vargas-Pinto, R., H. Gong, A. Vahabikashi, and M. Johnson. 2013. The Effect of the Endothelial Cell Cortex on Atomic Force Microscopy Measurements 3. Biophysical Journal. 105:300-309.
Whitsett, J., A. Rangel Filho, S. Sethumadhavan, J. Celinska, M. Widlansky, and J. Vasquez-Vivar. 2013. Human endothelial dihydrofolate reductase low activity limits vascular tetrahydrobiopterin recycling. Free Radical Biology and Medicine. 63:143-150.
Bernson, E. 2012. Development of a Microfluidic Platform for Cell migration Studies along Gradients. In Department of Applied Physics. MS Thesis, Chalmers University of Technology.
Cossu, A. 2012. Study of intracellular signaling pathways triggered by natural antioxidants in human endothelial cells. Università degli studi di Sassari, PhD dissertation.
Ding, S., D.M. Pinkas, and A.E. Barron. 2012. Synthesis and assembly of functional high molecular weight adiponectin multimers in an engineered strain of Escherichia coli. Biomacromolecules. 13:1035-1042.
Donneys, A., D.M. Weiss, S.S. Deshpande, S. Ahsan, C.N. Tchanque-Fossuo, D. Sarhaddi, B. Levi, S.A. Goldstein, and S.R. Buchman. 2012. Localized deferoxamine injection augments vascularity and improves bony union in pathologic fracture healing after radiotherapy. Bone. 52:318–325.
Forchhammer, L., S. Loft, M. Roursgaard, Y. Cao, I.S. Riddervold, T. Sigsgaard, and P. Møller. 2012. Expression of adhesion molecules, monocyte interactions and oxidative stress in human endothelial cells exposed to wood smoke and diesel exhaust particulate matter. Toxicology letters. 209:121-128.
Hisano, Y., N. Kobayashi, A. Yamaguchi, and T. Nishi. 2012. Mouse SPNS2 Functions as a Sphingosine-1-Phosphate Transporter in Vascular Endothelial Cells. PloS one. 7:e38941.
Jacky, B., P. Garay, Y. Molina, J. Francis, L. Steward, S. Ghanshani, T. Hunt, K. Aoki, and E. Fernandez-Salas. 2012.  Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted Endopeptidases. Patent Applications US 20120207704 A1. 
Jacky, B., P. Garay, Y. Molina, J. Francis, L. Steward, S. Ghanshani, T. Hunt, K. Aoki, and E. Fernandez-Salas. 2012.   Treating a Disease of Hyperproliferation Using Retargeted Endopeptidases. Patent Application US 20120207733 A1.
Jacky, B., P. Garay, Y. Molina, J. Francis, L. Steward, S. Ghanshani, T. Hunt, K. Aoki, and E. Fernandez-Salas. 2012.  Methods of Inhibiting Aberrant Blood Vessel Formation Using Opioid Retargeted Endpeptidases. Patent Application US 20120207734 A1.
Jacky, B., P. Garay, Y. Molina, J. Francis, L. Steward, S. Ghanshani, T. Hunt, G. Sachs, K. Aoki, and E. Fernandez-Salas. 2012.   Treatments Using PSMA Ligand Endopeptidases. US 20120207742 A1. 
Kawaguchi, K., F. Lambein, and K. Kusama-Eguchi. 2012. Vascular insult accompanied by overexpressed heme oxygenase-1 as a pathophysiological mechanism in experimental neurolathyrism with hind-leg paraparesis. Biochemical and biophysical research communications. 428:160-166.
Murai, A., S. Asa, A. Kodama, A. Hirata, T. Yanai, and H. Sakai. 2012. Constitutive phosphorylation of the mTORC2/Akt/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines. BMC Veterinary Research. 8:128.
Nakamura, D.S., A.K. Edwards, S. Virani, R. Thomas, and C. Tayade. 2012. Thrombospondin-1 Mimetic Peptide ABT-898 Affects Neovascularization and Survival of Human Endometriotic Lesions in a Mouse Model. The American journal of pathology. 181:570-582.
Namin, S.M. 2012. An Experimental and Theoretical Analysis of Nitric Oxide in the Microcirculation. PhD Dissertation, Florida International University.
Paolillo, R., M. Lovene, C. Carratelli, and A. Rizzo. 2012. Induction of VEGF and MMP-9 Expression by Toll-like Receptor 2/4 in Human Endothelial Cells Infected with Chlamydia Pneumoniae. Intl J Immunopathol & Pharmacol, 25:377-386.
Pfister, C., H. Pfrommer, M. Tatagiba, and F. Roser. 2012. Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro. British journal of cancer. 107:1702-1713.
Siegel, D., J.K. Kepa, and D. Ross. 2012. NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Localizes to the Mitotic Spindle in Human Cells 1. PloS one. 7:e44861.
Shao, M., S. Hollar, D. Chambliss, J. Schmitt, R. Emerson, B. Chelladurai, S. Perkins, M. Ivan, and D. Matei. 2012. Targeting the Insulin Growth Factor and the Vascular Endothelial Growth Factor Pathways in Ovarian Cancer. Molecular Cancer Therapeutics. 11:1576-1586. 
Takino, J., S. Yamagishi, and M. Takeuchi. 2012. Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression. World journal of gastroenterology: WJG. 18:1781.
Wang, X., Z. Zhang, and C. Yao. 2012. Bortezomib Inhibits the Angiogenesis Mediated by Mesenchymal Stem Cells. Cellular and Molec Biol, 30:657-662.
Xie, W., Z. Zhai, Y. Yang, T. Kuang, and C. Wang. 2012. Free fatty acids inhibit TM–EPCR expression through JNK pathway: an implication for the development of the prothrombotic state in metabolic syndrome. Journal of thrombosis and thrombolysis. 34:468-474.
Dayoub, J.C., F. Ortiz, L.C. L+Ýpez, C. Venegas, A. del Pino-Zumaquero, O. Roda, I. S+¡nchez-Montesinos, D.o. Acu+Ýa-Castroviejo, and G. Escames. 2011. Synergism between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide 9. Journal of Pineal Research. 51:324-330.
Jane, E.P., D.R. Premkumar, and I.F. Pollack. 2011. Bortezomib Sensitizes Malignant Human Glioma Cells to TRAIL, Mediated by Inhibition of the NF-κB Signaling Pathway. Molecular Cancer Therapeutics. 10:198-208.
Konakahara, S., M. Saitou, S. Hori, T. Nakane, K. Murai, R. Itoh, A. Shinsaka, J. Kohroki, T. Kawakami, M. Kajikawa, and Y. Masuho. 2011. A neuronal transmembrane protein LRFN4 induces monocyte/macrophage migration via actin cytoskeleton reorganization. FEBS letters. 585:2377-2384.
Mehta, R.R., T. Yamada, B.N. Taylor, K. Christov, M.L. King, D. Majumdar, F. Lekmine, C. Tiruppathi, A. Shilkaitis, and L. Bratescu. 2011. A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt. Angiogenesis. 14:355-369.
Mikkelsen, L., M. Sheykhzade, K.A. Jensen, A.T. Saber, N.R. Jacobsen, U. Vogel, H. Wallin, S. Loft, and P. Moller. 2011. Modest effect on plaque progression and vasodilatory function in atherosclerosis-prone mice exposed to nanosized TiO2. Part Fibre Toxicol. 8:32.
Mukai, R., H. Ashida, J. Terao, and N. Saito. 2011. Determination of Subcellular Localization of Flavonol in Cultured Cells by Laser Scanning. In Laser Scanning, Theory and Applications. C. Wang (Ed.), ISBN: 978-953-307-205-0.
Pauken, C.M., and M.R. Caplan. 2011. Temporal differences in Erk1/2 activity distinguish among combinations of extracellular matrix components. Acta Biomaterialia. 7:3973-3980.
Rivera, V.M., R.M. Squillace, D. Miller, L. Berk, S.D. Wardwell, Y. Ning, R. Pollock, N.I. Narasimhan, J.D. Iuliucci, and F. Wang. 2011. Ridaforolimus (AP23573; MK-8669), a potent mTOR inhibitor, has broad antitumor activity and can be optimally administered using intermittent dosing regimens. Molecular cancer therapeutics. 10:1059-1071.
Rössler, J., Y. Monnet, F. Farace, P. Opolon, E. Daudigeos-Dubus, A. Bourredjem, G. Vassal, and B. Geoerger. 2011. The selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor activity in human neuroblastoma xenografts. International Journal of Cancer. 128:2748-2758.
Sanna, V., G. Pintus, A.M. Roggio, S. Punzoni, A.M. Posadino, A. Arca, S. Marceddu, P. Bandiera, S. Uzzau, and M. Sechi. 2011. Targeted biocompatible nanoparticles for the delivery of (−)-epigallocatechin 3-gallate to prostate cancer cells. Journal of medicinal chemistry. 54:1321-1332.
Sharma, V., and H.H. Freeze. 2011a. Mannose Efflux from the Cells: A POTENTIAL SOURCE OF MANNOSE IN BLOOD. Journal of Biological Chemistry. 286:10193-10200.
Sharma, V., M. Ichikawa, P. He, Y. Bravo, R. Dahl, B. Ng, N. Cosford, and H. Freeze. 2011. Phosphomannose Isomerase Inhibitors Improve N-Glycosylation in Selected Phosphomannomutase-deficient Fibroblasts. JCB, 286:39431-39438.
Xu, H., M. Zaidi, J. Struve, D.W. Jones, J.G. Krolikowski, S. Nandedkar, N.L. Lohr, A. Gadicherla, P.S. Pagel, M.E. Csuka, K.A. Pritchard, and D. Weihrauch. 2011. Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosis. American Journal of Physiology - Cell Physiology. 300:C550-C556.
Yoshikawa, A., Y. Aizaki, K.-i. Kusano, F. Kishi, T. Susumu, S. Iida, S. Ishiura, S. Nishimura, M. Shichiri, and T. Senbonmatsu. 2011. The (pro)renin receptor is cleaved by ADAM19 in the Golgi leading to its secretion into extracellular space. Hypertension research. 34:599-605.
Edwards, D., M. Berens, and C. Beaudry. 2010. Cell migration inhibiting compositions and methods and compositions for treating cancer. Patent US 7700615 B2.
Heberlein, K., A. Straubb, A. Best, M. Greyson, R. Looft-Wilson, P. Sharma, A. Meher, N. Leitinger, and B. Isakson. 2010. Plasminogen Activator Inhibitor-1 Regulates Myoendothelial Junction Formation. Circulation Research, 106:1092-1102.
Jacky, B., P. Garay, Y. Molina, D. Stathakis, J. Francis, K. Aoki, and E. Fernandez-Salas. 2010. Methods of Treating Cancer Using Opioid Retargeted Endopepidases. Patent Application US 20110064713 A1.
Jacky, B. P. Garay, Y. Molina, D. Stathakis, J. Francis, K. Aoki, and E. Fernandez-Salas. 2010. Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopeptidases. Patent Application US 20110070212 A1.
Koai, E., T. Rios, and J. Edwards. 2010. Vascular Endothelial Growth Factor Increases Endothelial Nitric Oxide Synthase Transcription In Huvec Cells. WebmedCentral PHYSIOLOGY 2010;1(11):WMC001111, doi: 10.9754/journal.wmc.2010.001111.
Lionetti, V., S. Cantoni, C. Cavallini, F. Bianchi, S. Valente, I. Frascari, E. Olivi, G. Aquaro, F. Bonavita, I. Scarlata, M. Maioli, V. Vaccari, R. Tassinari, A. Bartoli, F. Recchia, G. Pasquinelli, and C. Ventura. 2010. Hyaluronan Mixed Esters of Butyric and Retinoic Acid Affording Myocardial Survival and Repair without Stem Cell Transplantation. JBC, 285:9949-9961.
Miyake, Y., M. Mochizuki, C. Ito, M. Itoigawa, and T. Osawa. 2010. Peroxynitrite Scavengers Produced by Filamentous Fungus Used in the Katsuobushi Manufacturing Process. Food science and technology research. 16:493-498.
Mochizuki, M., Y. Tsuchie, N. Yamada, Y. Miyake, and T. Osawa. 2010. Effect of sesame lignans on TNF-α-induced expression of adhesion molecules in endothelial cells. Bioscience, biotechnology, and biochemistry. 74:1539-1544.
Nivison-Smith, L., J. Rnjak, and A.S. Weiss. 2010. Synthetic human elastin microfibers: Stable cross-linked tropoelastin and cell interactive constructs for tissue engineering applications. Acta Biomaterialia. 6:354-359.
Pasciu, V., A.M. Posadino, A. Cossu, B. Sanna, B. Tadolini, L. Gaspa, A. Marchisio, S. Dessole, G. Capobianco, and G. Pintus. 2010. Akt Downregulation by Flavin Oxidase–Induced ROS Generation Mediates Dose-Dependent Endothelial Cell Damage Elicited by Natural Antioxidants. Toxicological Sciences. 114:101-112.
Patel, N.S., V.S. Mathura, C. Bachmeier, D. Beaulieu-Abdelahad, V. Laporte, O. Weeks, M. Mullan, and D. Paris. 2010. Alzheimer’s β-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2. Journal of Neurochemistry. 112:66-76.
Sheikh-Ali, M., S. Sultan, A.-R. Alamir, M.J. Haas, and A.D. Mooradian. 2010a. Effects of antioxidants on glucose-induced oxidative stress and endoplasmic reticulum stress in endothelial cells. Diabetes research and clinical practice. 87:161-166.
Sheikh-Ali, M., S. Sultan, A.-R. Alamir, M.J. Haas, and A.D. Mooradian. 2010b. Hyperglycemia-induced endoplasmic reticulum stress in endothelial cells. Nutrition. 26:1146-1150.
Thebaud, N. 2010. Cellules endothéliales issues de progéniteurs humains : des acteurs pertinents en ingénierie vasculaire? PhD Dissertation, L’UNIVERSITÉ BORDEAUX 2.
Zhang, Y., W. Schulte, D. Pink, K. Phipps, A. Zijlstra, J.D. Lewis, and D.M. Waisman. 2010. Sensitivity of Cancer Cells to Truncated Diphtheria Toxin. PloS one. 5:e10498.
Himmelhaus, M., and A. Francois. 2009. In-vitro sensing of biomechanical forces in live cells by a whispering gallery mode biosensor. Biosensors and Bioelectronics. 25:418-427.
Himmelhaus, M., and A. Francois. 2009. Method for sensing a biochemical and/or biomechanical process of a biological material and method for analyzing biological materials. Patent Application US 20110256577 A1.
Islam, M.K., N. Tsuji, T. Miyoshi, M.A. Alim, X. Huang, T. Hatta, and K. Fujisaki. 2009. The Kunitz-Like Modulatory Protein Haemangin Is Vital for Hard Tick Blood-Feeding Success. PLoS Pathog. 5:e1000497.
Kawashiro, Y., H. Fukata, K. Sato, H. Aburatani, H. Takigami, and C. Mori. 2009. Polybrominated diphenyl ethers cause oxidative stress in human umbilical vein endothelial cells. Human & Experimental Toxicology. 28:703-713.
Kimura, M., Y. Kato, D. Sano, K. Fujita, A. Sakakibara, N. Kondo, Y. Mikami, and M. Tsukuda. 2009. Soluble form of ephrinB2 inhibits xenograft growth of squamous cell carcinoma of the head and neck. International journal of oncology. 34:321-327.
Tang, S.Y., I.K. Cheah, H. Wang, and B. Halliwell. 2009. Notopterygium forbesii Boiss extract and its active constituent phenethyl ferulate attenuate pro-inflammatory responses to lipopolysaccharide in RAW 264.7 macrophages. A “protective” role for oxidative stress? Chemical research in toxicology. 22:1473-1482.
Wu, J.C., A. Chruscinski, V.A. De Jesus Perez, H. Singh, M. Pitsiouni, M. Rabinovitch, P.J. Utz, and J.P. Cooke. 2009. Cholinergic modulation of angiogenesis: role of the 7 nicotinic acetylcholine receptor. Journal of cellular biochemistry. 108:433-446.
Yang, P., T. Hong, Y. Chen, A. Yuan, and Y. Wu. 2009. COMPOSITION FOR TREATING CANCER AND USE THEREOF. Patent Application 20090197798 A1.
Yang, P., T. Hong, Y. Chen, A, Yuan, and Y. We. 2009. Synthetic anti-neuropilin 1 (NRP1) cyclic peptide containing RRXR motif. Patent US 7601693 B2.
Yanagida, K., K. Masago, H. Nakanishi, Y. Kihara, F. Hamano, Y. Tajima, R. Taguchi, T. Shimizu, and S. Ishii. 2009. Identification and Characterization of a Novel Lysophosphatidic Acid Receptor, p2y5/LPA6. Journal of Biological Chemistry. 284:17731-17741.
Yoshie, M., E. Miyajima, S. Kyo, and K. Tamura. 2009. Stathmin, a Microtubule Regulatory Protein, Is Associated with Hypoxia-Inducible Factor-1α Levels in Human Endometrial and Endothelial Cells. Endocrinology. 150:2413-2418.
Kim, C.-S., S.-B. Jung, A. Naqvi, T.A. Hoffman, J. DeRicco, T. Yamamori, M.P. Cole, B.-H. Jeon, and K. Irani. 2008. P53 Impairs Endothelium-Dependent Vasomotor Function Through Transcriptional Upregulation of P66shc. Circulation research. 103:1441-1450.
Madasamy, S. 2008. Multi-subunit biological complexes for treatment of plaque-associated diseases. Patent Application US 20090104121 A1.
Rocha, F.G., C.A. Sundback, N.J. Krebs, J.K. Leach, D.J. Mooney, S.W. Ashley, J.P. Vacanti, and E.E. Whang. 2008. The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. Biomaterials. 29:2884-2890.
Syeda, F., E. Tullis, A.S. Slutsky, and H. Zhang. 2008. Human neutrophil peptides upregulate expression of COX-2 and endothelin-1 by inducing oxidative stress. Am J Physiol 294:H2769-H2774.
Yamanaka, M., Y. Anada, Y. Igarashi, and A. Kihara. 2008. A splicing isoform of LPP1, LPP1a, exhibits high phosphatase activity toward FTY720 phosphate. Biochemical and biophysical research communications. 375:675-679.
Ali, M.A., H. Choy, A.A. Habib, and D. Saha. 2007. SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor. Neoplasia (New York, NY). 9:370.
Carratelli, C.R., R. Paolillo, and A. Rizzo. 2007. Chlamydia pneumoniae stimulates the proliferation of HUVEC through the induction of VEGF by THP-1. International Immunopharmacology. 7:287-294.
Hollingsworth, J.W., Z. Li, D.M. Brass, S. Garantziotis, S.H. Timberlake, A. Kim, I. Hossain, R.C. Savani, and D.A. Schwartz. 2007. CD44 regulates macrophage recruitment to the lung in lipopolysaccharide-induced airway disease. American journal of respiratory cell and molecular biology. 37:248.
Hong, T.-M., Y.-L. Chen, Y.-Y. Wu, A. Yuan, Y.-C. Chao, Y.-C. Chung, M.-H. Wu, S.-C. Yang, S.-H. Pan, J.-Y. Shih, W.-K. Chan, and P.-C. Yang. 2007. Targeting Neuropilin 1 as an Antitumor Strategy in Lung Cancer. Clinical Cancer Research. 13:4759-4768.
Mattagajasingh, I., C.-S. Kim, A. Naqvi, T. Yamamori, T.A. Hoffman, S.-B. Jung, J. DeRicco, K. Kasuno, and K. Irani. 2007. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proceedings of the National Academy of Sciences. 104:14855-14860.
Omori, N., H. Fukata, K. Sato, K. Yamazaki, K. Aida-Yasuoka, H. Takigami, M. Kuriyama, M. Ichinose, and C. Mori. 2007. Polychlorinated biphenyls alter the expression of endothelial nitric oxide synthase mRNA in human umbilical vein endothelial cells. Human & Experimental Toxicology. 26:811-816.
Shibata, M., J. Morimoto, H. Doi, S. Morishima, M. Naka, and Y. Otsuki. 2007. Electrogene therapy using endostatin, with or without suicide gene therapy, suppresses murine mammary tumor growth and metastasis. Cancer Gene Therapy, 14:268-278.
Wu, X., K. Mahadev, L. Fuchsel, R. Ouedraogo, S.-q. Xu, and B.J. Goldstein. 2007. Adiponectin suppresses IκB kinase activation induced by tumor necrosis factor-α or high glucose in endothelial cells: role of cAMP and AMP kinase signaling. American Journal of Physiology - Endocrinology and Metabolism. 293:E1836-E1844.
Zhao, X., J. Hu, and L. Yang. Identification of One Vasculature Specific Phage-displayed Peptide in Human Colon Cancer. J. Exp. Clin. Cancer Res., 26:509-514.
Kamiyoshi, A., T. Sakurai, Y. Ichikawa-Shindo, J. Fukuchi, H. Kawate, S.-i. Muto, Y.-i. Tagawa, and T. Shindo. 2006. Endogenous αCGRP protects against concanavalin A-induced hepatitis in mice. Biochemical and biophysical research communications. 343:152-158.
Edwards, D., M. Berens, and C. Beaudry. 2006. Cell migration inhibiting compositions and methods and compositions for treating cancer. Patent US 7012100 B1.
Haas, M.J., M.H. Horani, S.A. Parseghian, and A.D. Mooradian. 2006. Statins Prevent Dextrose-Induced Endothelial Barrier Dysfunction, Possibly Through Inhibition of Superoxide Formation. Diabetes. 55:474-479.
Horani, M.H., M.J. Haas, and A.D. Mooradian. 2006a. Saturated, unsaturated, and trans-fatty acids modulate oxidative burst induced by high dextrose in human umbilical vein endothelial cells. Nutrition. 22:123-127.
Horani, M.H., M.J. Haas, and A.D. Mooradian. 2006b. Suppression of Hyperglycemia-Induced Superoxide Formation and Endothelin-1 Gene Expression by Carvedilol. American Journal of Therapeutics. 13:2-7.
Shibata, M.-A., Y. Ito, J. Morimoto, K. Kusakabe, R. Yoshinaka, and Y. Otsuki. 2006b. In vivo electrogene transfer of interleukin-12 inhibits tumor growth and lymph node and lung metastases in mouse mammary carcinomas. The journal of gene medicine. 8:335-352.
Bernier, S.G., N. Taghizadeh, C.D. Thompson, W.F. Westlin, and G. Hannig. 2005. Methionine aminopeptidases type I and type II are essential to control cell proliferation. Journal of cellular biochemistry. 95:1191-1203.
Csiszar, A., K.E. Smith, A. Koller, G. Kaley, J.G. Edwards, and Z. Ungvari. 2005. Regulation of Bone Morphogenetic Protein-2 Expression in Endothelial Cells: Role of Nuclear Factor-κΒ Activation by Tumor Necrosis Factor-α, H2O2, and High Intravascular Pressure. Circulation. 111:2364-2372.
Kawamura, Y.I., R. Kawashima, R. Fukunaga, K. Hirai, N. Toyama-Sorimachi, M. Tokuhara, T. Shimizu, and T. Dohi. 2005. Introduction of Sda Carbohydrate Antigen in Gastrointestinal Cancer Cells Eliminates Selectin Ligands and Inhibits Metastasis. Cancer research. 65:6220-6227.
Miho, N., T. Ishida, N. Kuwaba, M. Ishida, K. Shimote-Abe, K. Tabuchi, T. Oshima, M. Yoshizumi, and K. Chayama. 2005. Role of the JNK pathway in thrombin-induced ICAM-1 expression in endothelial cells. Cardiovascular Research. 68:289-298.
Papaconstantinou, M.E., C.J. Carrell, A.O. Pineda, K.M. Bobofchak, F.S. Mathews, C.S. Flordellis, M.E. Maragoudakis, N.E. Tsopanoglou, and E. Di Cera. 2005. Thrombin Functions through Its RGD Sequence in a Non-canonical Conformation. Journal of Biological Chemistry. 280:29393-29396.
Takii, R., T. Kadowaki, A. Baba, T. Tsukuba, and K. Yamamoto. 2005. A Functional Virulence Complex Composed of Gingipains, Adhesins, and Lipopolysaccharide Shows High Affinity to Host Cells and Matrix Proteins and Escapes Recognition by Host Immune Systems. Infection and Immunity. 73:883-893.
Han, K.H., K.-H. Hong, J.-H. Park, J. Ko, D.-H. Kang, K.-J. Choi, M.-K. Hong, S.-W. Park, and S.-J. Park. 2004. C-Reactive Protein Promotes Monocyte Chemoattractant Protein-1—Mediated Chemotaxis Through Upregulating CC Chemokine Receptor 2 Expression in Human Monocytes. Circulation. 109:2566-2571.
Horani, M.H., M.J. Haas, and A.D. Mooradian. 2004. Rapid adaptive down regulation of oxidative burst induced by high dextrose in human umbilical vein endothelial cells. Diabetes Research and Clinical Practice. 66:7-12.
Kasuya, H., T.M. Pawlik, J.T. Mullen, J.M. Donahue, H. Nakamura, S. Chandrasekhar, H. Kawasaki, E. Choi, and K.K. Tanabe. 2004. Selectivity of an Oncolytic Herpes Simplex Virus for Cells Expressing the DF3/MUC1 Antigen. Cancer research. 64:2561-2567.
Gustafson, D.L., D. Siegel, J.C. Rastatter, A.L. Merz, J.C. Parpal, J.K. Kepa, D. Ross, and M.E. Long. 2003. Kinetics of NAD(P)H:Quinone Oxidoreductase I (NQO1) Inhibition by Mitomycin C in Vitro and in Vivo. J. Pharmacol. & Exp. Therapeutics. 305:1079-1086.  
Han, K.H., Y. Chen, M.K. Chang, Y.C. Han, J.-H. Park, S.R. Green, A. Boullier, and O. Quehenberger. 2003. LDL activates signaling pathways leading to an increase in cytosolic free calcium and stimulation of CD11b expression in monocytes. Journal of lipid research. 44:1332-1340.
Hirono, S., E. Dibrov, C. Hurtado, A. Kostenuk, R. Ducas, and G.N. Pierce. 2003. Chlamydia pneumoniae Stimulates Proliferation of Vascular Smooth Muscle Cells Through Induction of Endogenous Heat Shock Protein 60. Circulation research. 93:710-716.
Li, Y., F. Spencer, and R. Becker. 2003. Plasmin-Mediated Proteolysis of Vascular Endothelial Cell Heparin Releasable Tissue Factor Pathway Inhibitor.  Journal of Thrombosis and Thrombolysis, 15:19-23.
Lu, T.-S., H.-W. Chen, S.-I. Lue, S.-J. Wang, M.-F. Kuo, and R.-C. Yang. 2003. The protective mechanism of heat shock treatment on the disruption of tight junction of endothelial cells. In FASEB JOURNAL. Vol. 17. FEDERATION AMER SOC EXP BIOL 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA. A64-A64.
Mori, C. 2003. Application of Toxicogenomic Analysis to Risk Assessment of Delayed Long-Term Effects of Multiple Chemicals Including Endocrine Disruptors in Human Fetuses. Environ Health Perspect, 111:803-804.
Ueshima, J., M. Shoji, D.B. Ratnayake, K. Abe, S. Yoshida, K. Yamamoto, and K. Nakayama. 2003. Purification, Gene Cloning, Gene Expression, and Mutants of Dps from the Obligate Anaerobe Porphyromonas gingivalis. Infection and Immunity. 71:1170-1178.
Montes, R.A.O., J.R. Eckman, L.L. Hsu, and T.M. Wick. 2002. Sickle erythrocyte adherence to endothelium at low shear: Role of shear stress in propagation of vaso-occlusion. American Journal of Hematology. 70:216-227.
Mullen, J.T., H. Kasuya, S.S. Yoon, N.M. Carroll, T.M. Pawlik, S. Chandrasekhar, H. Nakamura, J.M. Donahue, and K.K. Tanabe. 2002. Regulation of herpes simplex virus 1 replication using tumor-associated promoters. Annals of surgery. 236:502.
Sato, S., N. Ouellet, I. Pelletier, M. Simard, A. Rancourt, and M.G. Bergeron. 2002. Role of Galectin-3 as an Adhesion Molecule for Neutrophil Extravasation During Streptococcal Pneumonia. The Journal of Immunology. 168:1813-1822.
Wittmann, V., A.K. Datta, K.M. Koeller, and C.-H. Wong. 2000. Chemoenzymatic synthesis and fluorescent visualization of cell-surface selectin-bound sialyl Lewis x derivatives. CHEMISTRY-WEINHEIM-EUROPEAN JOURNAL-. 6:162-171.
Starnes, J. 1998. Alteration of Immune Responses by Cocaine: Cytokines and Reactive Nitrogen Intermediates. Masters Thesis, Texas Tech University, http://hdl.handle.net/2346/16554.

For general cryopreservation of most primary cells. Contains FBS & DMSO. 040-50 5944.53 руб.

HUVEC Total Kit: Media, Subculture Reagents & Cells, Fetal 200K-05f 55165.87 руб.
HUVEC Total Kit: Media, Subculture Reagents & Cells, Neonatal 200K-05n 46248.43 руб.
HUVEC Total Kit: Media, Subculture Reagents & Cells, Pooled, Neonatal 200pK-05n 38520.8 руб.

HUVEC Total Kit: Media, Subculture Reagents & Cells, Pre-Screened, Neonatal S200K-05n 63488.09 руб.

Cryopreserved HUVEC 200-05f 38639.45 руб.

Cryopreserved Ampoule, pooled 200p-05n 21995.02 руб.
Cryopreserved HUVEC 200-05n 29722.66 руб.

Cryopreserved HUVEC S200-05n 46962.32 руб.

25 x 24-Well Rxns TF200KS 5938.7 руб.
250 x 24-Well Rxns TF200K 31506.4 руб.

Basal medium (contains no growth supplement).В  Add GS before use. 210-500 7727.63 руб.
Basal medium without growth supplement and phenol red 210PR-500 8322.21 руб.

Basal medium & growth supplement sold together packaged separately 211K-500 13672.81 руб.

Starvation medium without phenol red 209PR-250 8678.83 руб.
Use when cells need to be starved overnight to 24 hrs before experiment 209-250 7727.63 руб.

Proliferating HUVEC 201-6Wf 61229.06 руб.
Proliferating HUVEC 201-96Wf 75495.81 руб.
Proliferating HUVEC 201-25f 38639.45 руб.
Proliferating HUVEC 201-75f 61229.06 руб.

Proliferating HUVEC 201-25n 29722.66 руб.
Proliferating HUVEC 201-75n 52312.26 руб.
Proliferating HUVEC 201-6Wn 52312.26 руб.
Proliferating HUVEC 201-96Wn 66579.01 руб.
Proliferating HUVEC, pooled 201p-25n 21995.02 руб.
Proliferating HUVEC, pooled 201p-75n 44583.98 руб.
Proliferating HUVEC, pooled 201p-6Wn 44583.98 руб.
Proliferating HUVEC, pooled 201p-96Wn 58851.38 руб.

Proliferating HUVEC S201-25n 46962.32 руб.
Proliferating HUVEC S201-96Wn 83818.67 руб.
Proliferating HUVEC S201-75n 69551.27 руб.
Proliferating HUVEC S201-6Wn 69551.27 руб.

100 ml each of HBSS, Trypsin/EDTA & Trypsin Neutralizing Solution 090K 6063.19 руб.

Extended Family Products

100 tests 028-S 3963.02 руб.
500 tests 028-01 15337.25 руб.

Total RNA prepared from Human Umbilical Vein Endothelial Cells, neonatal 200-R10n 38639.45 руб.
Total RNA prepared from Human Umbilical Vein Endothelial Cells, neonatal 200-R25n 77279.55 руб.
Total RNA prepared from Human Umbilical Vein Endothelial Cells, Stimulated, neonatal 200S-R10n 45178.57 руб.
Total RNA prepared from Human Umbilical Vein Endothelial Cells, Stimulated, neonatal 200S-R25n 90357.13 руб.

Related Products

Defined medium without serum 113-500 12483.65 руб.
Defined medium without serum and phenol red 113PR-500 13078.23 руб.

All-in-one ready-to-use 211-500 11651.1 руб.
Growth medium without antibiotics 211A-500 12483.65 руб.
Growth medium without FBS 211F-500 12483.65 руб.
Growth medium without hydrocortisone 211H-500 12483.65 руб.
Growth medium without phenol red 211PR-500 12483.65 руб.

Added to Basal Medium to create Growth Medium 211-GS 6301.15 руб.
Growth supplement without antibiotics 211A-GS 7490.32 руб.
Growth supplement without FBS 211F-GS 7727.63 руб.
Growth supplement without hydrocortisone 211H-GS 7490.32 руб.

HUVEC Conditioned Medium 211CM-05 5349.95 руб.

Информация представлена исключительно в ознакомительных целях и ни при каких условиях не является публичной офертой